Isolation of Cells From Biopsy Tissue to Aid in Kidney Repair
Public ClinicalTrials.gov record NCT04896567. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Endothelial progenitor cells that reside in renal vasculature may be stimulated to initiate differentiation programs during episodes of injury. It is hypothesized that endothelial progenitor cells resident in the kidney can transition to a post-injury phenotype that promotes endothelial repair.
Study identification
- NCT ID
- NCT04896567
- Recruitment status
- Withdrawn
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 20, 2022
- Primary completion
- Dec 29, 2023
- Completion
- Dec 29, 2024
- Last update posted
- Aug 2, 2022
2022 – 2024
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Kidney Diseases trials
Other public records listing Kidney Diseases. Sorted by last update posted; newest first. Not a recommendation.
- NCT04615819: Access to Kidney Transplantation in Minority Populations Active, not recruiting
- NCT06858319: Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy. Recruiting
- NCT07194733: Supporting VETerans With Kidney Disease Through Food As Medicine Recruiting
- NCT06810622: NAVIGATE Kidney: A Multi-level Intervention to Reduce Kidney Health Disparities Recruiting
- NCT05100017: Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure Active, not recruiting
- NCT07217535: Rutgers University Study of the Genetics of Kidney Disease Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04896567, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 2, 2022 · Synced Sep 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04896567 live on ClinicalTrials.gov.